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Background and purpose: Paroxysmal atrial fibrillation and flutter are strong risk factors for
stroke. Due to high recurrence rate of ischemic events and given the benefit of oral anti-
coagulation over antiplatelet drugs, it is important to identify this arrhythmia. Unfortu-
nately, paroxysmal AF or flutter is asymptomatic in majority and therefore, difficult to
detect.
Methods: Consecutive patients presenting with symptoms of acute ischemic stroke or
transient ischemic attack were included. All patients free of AF or flutter on presentation
underwent 24 h Holter monitoring within 7 days of admission.
Results: Overall, fifty two (52) patients (mean age 59.51  13.45 years) with acute stroke
(80.8%) and TIA (19.8%) underwent 24 h Holter monitoring. Paroxysmal AF was detected in
3 cases (5.8%), all 3 patients had acute stroke and were older than age 60 years. Type of
stroke was the only factor which was associated with greater risk of having paroxysmal AF
or flutter, AF accounted for 50% cases (2 out of 4) of clinically suspected cardio embolic
stroke.
Conclusion: Screening consecutive patients with ischemic stroke with routine Holter
monitoring will identify new atrial fibrillation/flutter in approximately one in 17 patients.
Older age and type of stroke are strongly associated with increased risk. By carefully
selecting the patients, the detection rates could be further increased.
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Atrial fibrillation (AF) and flutter are strong risk factors for
stroke and identifying them is an important part of the etio-
logical work up of patients with acute ischemic stroke orhatta, 530, Opp. Ram Man
om, rbagarhatta@yahoo.c
2014, Cardiological Societransient ischemic attack (TIA). Atrial fibrillation and flutter
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strokes.1 Stroke associated with AF carries a poor prognosis as
more than 50% of the survivors remain with a severe deficit,
and recurrence may be as high as 12% per year.2 Treatment
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antiplatelet therapy3; therefore it is important to identify this
arrhythmia. Unfortunately, AF remains under diagnosed as it
is often asymptomatic with up to 30% of patients unaware of
their diagnosis,4 moreover paroxysmal atrial fibrillation is
intermittent and has been reported to be asymptomatic in up
to 90% of the patients, therefore it is difficult to detect.5,6
However, the risk of thromboembolism purported by atrial
fibrillation is same whether paroxysmal or permanent.7
Because of poor sensitivity of single standard ECG for
detection of paroxysmal AF, 24 h Holter study is a better op-
tion, allowing the detection of previously unrecognized AF.
Also the probability of detecting atrial fibrillation may be
higher in the acute phase due to clustering of episodes of the
arrhythmia,8,9 making early initiation of monitoring
advantageous.
In this studywe examined feasibility and detection rates of
atrial fibrillation with 24 h Holter monitoring applied early
(within 7 days of admission) in patients presenting with acute
stroke or transient ischemic attack (TIA).2. Material and methods
We enrolled 52 patients admitted with a diagnosis of acute
stroke or TIA to the Neurology and Medicine Department of
S.M.S Hospital, Jaipur, India. Patients with previously diag-
nosed persistent or paroxysmal AF, primary hemorrhagic
stroke, acute large vessel dissection or inability or refusal of
consent were excluded from the study.
Baseline characteristics were recorded including a detailed
medical history andmajor risk factors. All patients underwent
detailed neurological examination, standard laboratory tests,
extra cranial carotid duplex ultrasonography, transthoracic
echocardiography and a neuroimaging study (cerebral CT
scan or cerebral MRI or both).3. Electrographic studies
All patients had a standard 12-lead ECG at admission. Addi-
tional ECG was performed if any arrhythmia was suspected on
clinical grounds. In absence of any evidence of AF, the patients
were recruited into the study group and after written informed
consent, a 24 h 12 channel Holter (H-SCRIBE, Mortara in-
struments, Inc. Milwaukee USA.) monitor was applied within 7
days of symptomonset by specifically trainedmedical staff and
monitors were collected for analysis after 24 h. Electrographic
recordings were later on analyzed offline with a focus on
detecting atrial fibrillation or flutter. Heart rate and RR vari-
ability plots were checked for patterns suggestive of atrial
fibrillation. Supraventricular premature complexes, supraven-
tricular tachycardia, ventricular premature complexes and
ventricular tachycardia as detected by the automated software
algorithm were scanned. Electrographic strips representing
fastest and slowest heart rates were also inspected and inten-
sivemanual reviewwasalsoundertakenformostof thecases.10
Results of the Holter study were communicated to
respective treating physicians and any change of therapy was
solely left to the discretion of treating physician.4. Definitions and statistical analysis
Etiology of the stroke was classified according to Trial of org in
Acute Stroke Treatment (TOAST) classification scheme.11
Transient ischemic attack was defined as sudden, focal neuro-
logical deficit of presumedvascular origin lasting less than 24h.
Presence of atrial fibrillation was defined as at least 1 period of
>30 s duration. Episodes of frequent supraventricular ectopy
(>10 supraventricular complexes in a row) were also recorded.
Discrete categorical data were presented as n (%);
Normality of quantitative data was checked by measures of
Kolmogorov Smirnov tests of normality. Continuous data
were given as mean  SD, range or as median and inter-
quartile range as appropriate. ManneWhitney U-test was
used for statistical analysis of continuous variables. For cat-
egorical data comparisons were made by Pearson Chi-square
test or Fisher’s exact test as appropriate. All statistical tests
were two-sided and performed at a significance level of
a ¼ 0.05. Analysis was conducted using SPSS for Windows
(version 15.0; SPSS Inc., Chicago, IL, USA).5. Results
Total 52 patients of acute stroke or transient ischemic attack
(TIA) were finally enrolled in our study after ruling out those
with exclusion criteria. 42 (80.8%) had acute ischemic stroke
and 10 (19.2%) had TIA. Baseline clinical characteristics are
summarized in Table 1. All patients had their Holter moni-
toring initiated within 7 days of admission. In 31 cases (59.6%)
it was started on day 2 of admission, in 17 cases (32.7%) on day
3 and in remaining 4 cases (4.7%) on day 4.
Routine transthoracic echocardiogram was done in all
cases, 8 patients (15.4%) had evidence of left ventricular hy-
pertrophy (LVH) and one patient had severe left ventricular
dysfunction secondary to old myocardial infarction.
In our study we found 3 cases (5.8%) of paroxysmal AF
among 52 patients. All patients had acute ischemic stroke, and
were older in age (Table 2). One patient had single episode of
AF of 4min durationwhile other 2 cases hadmultiple episodes
lasting several seconds to few minutes (Fig. 1). None of the
patients reported any symptoms during the recording period.
Neither prior history of stroke or TIA, nor prior history of
palpitations was associated with greater risk of having
paroxysmal AF or flutter. Only factor which was found to be
significantly associated with risk of AF or flutter was the type
of stroke, AF was present among 2 out of 4 cases of suspected
cardio embolic stroke on the basis of clinical presentation and
neuroimaging data.6. Discussion
In the present study, paroxysmal AF was detected in 3 (5.8%)
cases, beyond that was detected by physical examination and
initial electrocardiogram on presentation, thus identifying AF
in approximately one in 17 patients. Detection rates are
similar to those reported by earlier studies (3.9%e5.5%).12,13
Importantly paroxysmal AF accounted for 50% (2 out of 4) of
Table 1 e Patient characteristics (n[ 52).
Age 59.51  13.45 years
Sex
Male 40 (76.9%)
Female 12 (23.1%)
TIA 10 (19.2%)
Stroke 42 (80.8%)
Toast classification
Cardioembolic 4 (9.5%)
Large vessel 17 (40.47%)
Lacunar 5 (11.90%)
Undetermined 16 (38.10%)
History of stroke 4 (7.7%)
History of TIA 10 (19.2%)
History of palpitations 15 (28.8%)
Diabetes 12 (23.1%)
Hypertension 27 (51.9%)
Smoking 28 (53.8%)
Coronary artery disease 8 (15.4%)
Echo
LVH 8 (15.4%)
LV 1 (1.7%)
Dysfunction
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patients with lacunar stroke had AF. However, because of
small number of patients enrolled, this study is underpowered
to make definite conclusions about relation of paroxysmal AF
with regards to lacunar stroke but similar findings were also
observed in studies done by Jabaudon et al14 and Stahrenberg
et al,10 in which no cases of new AFwere seen in patients with
lacunar stroke. By excluding such patients, including the ones
with suspected cardio embolic stroke and those with some
underlying risk factors for cardiovascular disease, we expect
the yield could be further increased.Table 2 e Comparison of patients with or without atrial
fibrillation.
AF present
(n ¼ 3)
AF absent
(n ¼ 49)
p Value
Age 70.67 
10.01 years
58.86 
13.26 years
NS
Sex
Male 3 (100%) 12 (41.3%) NS
Female 0 (0.0%) 37 (58.7%)
TIA 0 (0.0%) 10 (38.77%) NS
Stroke 3 (100.0%) 39 (61.23%) NS
Toast classification
Cardioembolic 2 (66.67%) 2 (5.13%) P ¼ 0.03
Large vessel 0 (0.0%) 17 (43.59%)
Lacunar 0 (0.0%) 5 (12.82%)
Undetermined 1 (33.33%) 15 (38.46%)
History of stroke 0 (0.0%) 4 (8.16%) NS
History of TIA 1 (33.33%) 2 (4.08%) NS
History of palpitations 2 (66.67%) 13(26.53%) NS
Diabetes 1 (33.33%) 11 (22.45%) NS
Hypertension 2 (66.67%) 25 (51.02%) NS
Smoking 3 (100.00%) 25 (51.02%) NS
Coronary artery disease 1 (33.33%) 7 (14.28%) NS
Echo
LVH 1 (33.33%) 7 14.29%) NS
LV 0 (0.0%) 1 (2.08%)
Dysfunction
LVEF 58.33  5.77% 56.51  4.56%American heart and stroke association (AHA/ASA) recom-
mends that all patients with acute cerebral ischemia should
undergo cardiovascular evaluation including monitoring of
cardiac rhythm on telemetry or by Holter monitoring for
detection of atrial fibrillation or other serious arrhythmias,
both for determination of the cause of the stroke and to
optimize immediate and long-term management, but still
Holter monitoring remains an underutilized investigation in
routine clinical practice in our country.
Interestingly all patients of acute stroke undergo routine
carotid Doppler on admission in most institutions and
detection rate reported in literature for carotid ultrasound in
acute stroke is about 7.9%.15 Therefore, we expect that by
carefully selecting the patients undergoing Holter, its yield
can be increased to match that of carotid ultrasound study.
Because recurrence of stroke in AF is 3e5% in first few
weeks after initial event16,17 and up to 12% in untreated pa-
tients in first two to three years3,18 and since oral anti-
coagulation significantly reduces the risk of recurrent stroke
and systemic embolism in patients with persistent or parox-
ysmal AF as compared to aspirin (1.5 vs. 4.7 events per 100
patient years),19 it is important to identify this arrhythmia.
Now with the advent of new generation of novel oral antico-
agulants which do not have any monitoring issues, treatment
of these patients will become easier with significant relative
risk reduction for secondary ischemic events.
The ideal timing and duration of monitoring is an issue
which still remains unresolved. Increased duration of moni-
toring has been reported to be associated with increased
detection rates. In the 2 studies that evaluated event loop re-
corders (ELR) new AF was detected in 5.7% and 7.7% cases
respectively.13,14 In a study by Stahrenberg et al10 which
evaluated early and prolonged 7 day continuous Holter
monitoring, new AF was detected in 12.5% of cases. In their
study Holter monitoring was initiated on day of admission in
the emergency department itself and detection rates for every
single day were evaluated and they found that there was no
significant pattern favoring any given period or day, and
importantly there was no evidence for a higher detection on
day 1. Thus starting monitoring very early may not be that
much crucial, however a very prolonged delay between
symptom onset and Holter monitoring may render causal
relationship between arrhythmia and stroke debatable.
Jabaudon et al14 evaluated the use of both Holter and ELR
(for Holter negative patients) for detection of paroxysmal AF
and in their study number needed to screen (NNS) values for
both were comparable (18 vs. 20); therefore authors suggested
that stepwise sequential workup should be followed. In our
opinion also, this is a better approach since wearing ELR or a
prolonged 7 dayHoltermonitor is cumbersome, the analysis is
time consuming and it delays the results, therefore it is better
to start with Holter first and those patients who are Holter
negative but have high risk of paroxysmal arrhythmias be
subjected to prolonged monitoring.7. Study limitations
Sample size of our study was small, which is a clear limitation
of this study. Second, only hospitalized patients were included
Fig. 1 e Holter tracing of a patient with acute ischemic stroke shows run of paroxysmal AF.
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population. Thirdly, change in therapy was left to the discre-
tion of treating physician and those patients were not pro-
spectively followed for occurrence of recurrent events.8. Conclusions
In conclusion, screening patients with acute ischemic stroke
or TIA will identify new paroxysmal AF or flutter in approxi-
mately one in 17 patients with normal standard ECG. By
confining its use to selected patient population, its diagnostic
yield may be further increased. Given the benefit of oral
anticoagulation in this setting Holter monitoring will allow
introduction of appropriate treatment and better secondary
prevention.Conflicts of interest
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